Total Payments
$39,265
2020 Payments
$3,000
Companies
2
Transactions
80
Medicare Patients
1,892
Medicare Billing
$231,317
Payment Breakdown by Category
Other$30,176 (76.9%)
Travel$6,000 (15.3%)
Food & Beverage$1,588 (4.0%)
Consulting$1,500 (3.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $30,176 | 16 | 76.9% |
| Travel and Lodging | $6,000 | 32 | 15.3% |
| Food and Beverage | $1,588 | 30 | 4.0% |
| Consulting Fee | $1,500 | 2 | 3.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $38,747 | 72 | $0 (2020) |
| LivaNova USA, Inc. | $517.71 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $3,000 | 2 | UCB, Inc. ($3,000) |
| 2019 | $2,210 | 16 | UCB, Inc. ($1,692) |
| 2018 | $2,756 | 5 | UCB, Inc. ($2,756) |
| 2017 | $31,299 | 57 | UCB, Inc. ($31,299) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/06/2020 | UCB, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| 01/06/2020 | UCB, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| 12/09/2019 | UCB, Inc. | Briviact (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: Neurology | ||||||
| 11/12/2019 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Neurology | ||||||
| 11/07/2019 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $8.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2019 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $33.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/20/2019 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: Neurology | ||||||
| 09/03/2019 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $8.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/06/2019 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $180.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/29/2019 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $41.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/28/2019 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Neurology | ||||||
| 06/19/2019 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $48.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/06/2019 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $175.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/25/2019 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/12/2019 | UCB, Inc. | Vimpat (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Neurology | ||||||
| 01/29/2019 | UCB, Inc. | Briviact (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: Neurology | ||||||
| 01/24/2019 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $91.86 | General |
| 01/16/2019 | UCB, Inc. | Vimpat (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Neurology | ||||||
| 12/20/2018 | UCB, Inc. | Vimpat (Drug) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: Neurology | ||||||
| 11/29/2018 | UCB, Inc. | Vimpat (Drug) | Food and Beverage | In-kind items and services | $2.11 | General |
| Category: Neurology | ||||||
| 05/21/2018 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Neurology | ||||||
| 05/21/2018 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $127.53 | General |
| Category: Neurology | ||||||
| 05/10/2018 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $98.82 | General |
| Category: Neurology | ||||||
| 11/29/2017 | UCB, Inc. | Vimpat (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Neurology | ||||||
| 11/29/2017 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,200.00 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 502 | 751 | $113,411 | $59,011 |
| 2022 | 7 | 622 | 932 | $157,529 | $75,793 |
| 2021 | 7 | 374 | 522 | $93,963 | $47,340 |
| 2020 | 7 | 394 | 550 | $96,180 | $49,174 |
Total Patients
1,892
Total Services
2,755
Medicare Billing
$231,317
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 112 | 245 | $42,491 | $22,324 | 52.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 159 | 164 | $41,903 | $21,696 | 51.8% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 200 | 307 | $25,453 | $13,161 | 51.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 20 | $2,335 | $1,186 | 50.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 12 | 15 | $1,230 | $643.05 | 52.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 177 | 186 | $55,926 | $28,012 | 50.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 156 | 340 | $54,594 | $26,660 | 48.8% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 148 | 207 | $20,002 | $9,156 | 45.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 70 | 86 | $8,563 | $3,771 | 44.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 40 | 69 | $8,800 | $3,770 | 42.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 14 | 20 | $7,323 | $3,356 | 45.8% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Facility | 2022 | 17 | 24 | $2,322 | $1,068 | 46.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 129 | 134 | $40,242 | $20,732 | 51.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 91 | 171 | $26,512 | $13,619 | 51.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 33 | 65 | $7,815 | $3,615 | 46.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 17 | 20 | $6,625 | $3,403 | 51.4% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 50 | 61 | $5,901 | $2,750 | 46.6% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2021 | 37 | 49 | $4,740 | $2,223 | 46.9% |
| 95822 | Measurement and recording of brain wave (eeg) activity, in coma or asleep | Facility | 2021 | 17 | 22 | $2,128 | $997.92 | 46.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 124 | 126 | $37,981 | $19,539 | 51.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 108 | 201 | $31,163 | $16,446 | 52.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 17 | 21 | $6,956 | $3,488 | 50.1% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 48 | 61 | $5,711 | $2,796 | 49.0% |
| 95822 | Measurement and recording of brain wave (eeg) activity, in coma or asleep | Facility | 2020 | 33 | 51 | $4,723 | $2,348 | 49.7% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2020 | 41 | 50 | $4,837 | $2,302 | 47.6% |
About Dr. Jeffrey Harris, M.D
Dr. Jeffrey Harris, M.D is a Neurology healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1639165749.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Harris, M.D has received a total of $39,265 in payments from pharmaceutical and medical device companies, with $3,000 received in 2020. These payments were reported across 80 transactions from 2 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($30,176).
As a Medicare-enrolled provider, Harris has provided services to 1,892 Medicare beneficiaries, totaling 2,755 services with total Medicare billing of $231,317. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location San Antonio, TX
- Active Since 09/23/2005
- Last Updated 08/31/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1639165749
Products in Payments
- Vimpat (Drug) $17,910
- Briviact (Drug) $17,746
- VNS Therapy (Device) $517.71
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in San Antonio
Ann Bass, M.d, M.D
Neurology — Payments: $2.4M
Neurology $2.4M
Dr. Santiago Restrepo
Neurology — Payments: $534,626
Neurology $534,626
Dr. Juan Ramirez Castaneda, M.d, M.D
Neurology — Payments: $298,865
Neurology $298,865
Dr. Maria Alvarez, M.d, M.D
Neurology — Payments: $184,216
Neurology $184,216
Dr. Rebecca Romero, Md, MD
Neurology — Payments: $165,343
Neurology $165,343
Dr. Lee Birnbaum, M.d, M.D
Neurology — Payments: $131,531
Neurology $131,531